Oncternal Therapeutics Price Prediction
| ONCTDelisted Stock | USD 0.53 0.00 0.00% |
Oversold Vs Overbought
33
Oversold | Overbought |
Using Oncternal Therapeutics hype-based prediction, you can estimate the value of Oncternal Therapeutics from the perspective of Oncternal Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Oncternal Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Oncternal because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Oncternal Therapeutics after-hype prediction price | USD 0.42 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Oncternal |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Oncternal Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Oncternal Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Oncternal Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Oncternal Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Oncternal Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Oncternal Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Oncternal Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Oncternal Therapeutics' historical news coverage. Oncternal Therapeutics' after-hype downside and upside margins for the prediction period are 0.02 and 11.30, respectively. We have considered Oncternal Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Oncternal Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of Oncternal Therapeutics is based on 3 months time horizon.
Oncternal Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Oncternal Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Oncternal Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Oncternal Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
3.87 | 10.88 | 1.04 | 0.34 | 6 Events / Month | 12 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.53 | 0.42 | 20.53 |
|
Oncternal Therapeutics Hype Timeline
Oncternal Therapeutics is now traded for 0.53. The entity has historical hype elasticity of -1.04, and average elasticity to hype of competition of -0.34. Oncternal is forecasted to decline in value after the next headline, with the price expected to drop to 0.42. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -20.53%, whereas the daily expected return is now at -3.87%. The volatility of related hype on Oncternal Therapeutics is about 12330.67%, with the expected price after the next announcement by competition of 0.19. The company has price-to-book ratio of 0.17. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Oncternal Therapeutics recorded a loss per share of 11.69. The entity last dividend was issued on the 10th of June 2019. The firm had 1:20 split on the 8th of January 2024. Given the investment horizon of 90 days the next forecasted press release will be in about 6 days. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.Oncternal Therapeutics Related Hype Analysis
Having access to credible news sources related to Oncternal Therapeutics' direct competition is more important than ever and may enhance your ability to predict Oncternal Therapeutics' future price movements. Getting to know how Oncternal Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Oncternal Therapeutics may potentially react to the hype associated with one of its peers.
Oncternal Therapeutics Additional Predictive Modules
Most predictive techniques to examine Oncternal price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Oncternal using various technical indicators. When you analyze Oncternal charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Oncternal Therapeutics Predictive Indicators
The successful prediction of Oncternal Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Oncternal Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Oncternal Therapeutics based on analysis of Oncternal Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Oncternal Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Oncternal Therapeutics's related companies.
Story Coverage note for Oncternal Therapeutics
The number of cover stories for Oncternal Therapeutics depends on current market conditions and Oncternal Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Oncternal Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Oncternal Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Oncternal Therapeutics Short Properties
Oncternal Therapeutics' future price predictability will typically decrease when Oncternal Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Oncternal Therapeutics often depends not only on the future outlook of the potential Oncternal Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oncternal Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.9 M | |
| Cash And Short Term Investments | 34.3 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Oncternal Stock
If you are still planning to invest in Oncternal Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncternal Therapeutics' history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |